6533b86ffe1ef96bd12cdefe

RESEARCH PRODUCT

Corneal Epithelial Stem Cells-Physiology, Pathophysiology and Therapeutic Options.

Adrian GerickeAytan MusayevaNorbert PfeifferSubao JiangYue Ruan

subject

QH301-705.5PhysiologyReviewCorneal DiseasesCorneaCorneamedicineAnimalsHumansBiology (General)Corneal epitheliumbusiness.industrylimbusRegeneration (biology)Stem CellsEpithelium CornealEpithelial CellsGeneral Medicinemedicine.diseaseEpitheliumPathophysiologyeye diseasesTransplantationnichemedicine.anatomical_structuregraftsense organsStem cellbusinessepitheliumDyskeratosis congenitastem cell deficiencyStem Cell Transplantationtransplantation

description

In the human cornea, regeneration of the epithelium is regulated by the stem cell reservoir of the limbus, which is the marginal region of the cornea representing the anatomical and functional border between the corneal and conjunctival epithelium. In support of this concept, extensive limbal damage, e.g., by chemical or thermal injury, inflammation, or surgery, may induce limbal stem cell deficiency (LSCD) leading to vascularization and opacification of the cornea and eventually vision loss. These acquired forms of limbal stem cell deficiency may occur uni- or bilaterally, which is important for the choice of treatment. Moreover, a variety of inherited diseases, such as congenital aniridia or dyskeratosis congenita, are characterized by LSCD typically occurring bilaterally. Several techniques of autologous and allogenic stem cell transplantation have been established. The limbus can be restored by transplantation of whole limbal grafts, small limbal biopsies or by ex vivo-expanded limbal cells. In this review, the physiology of the corneal epithelium, the pathophysiology of LSCD, and the therapeutic options will be presented.

10.3390/cells10092302https://pubmed.ncbi.nlm.nih.gov/34571952